Evidence map›Paper›PMID 35653374›Full record

ArticleRNA biology2022

Sensitive and accurate analysis of gene expression signatures enabled by oligonucleotide-labelled cDNA.

Žana Kapustina, Justina Medžiūnė, Varvara Dubovskaja, Karolis Matjošaitis, Simona Žeimytė, Arvydas Lubys

Abstract read
In one paragraph

Article in RNA biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Žana KapustinaThermo Fisher Scientific Baltics, Research and Development Department, Vilnius, Lithuania.ORCID 0000-0002-1482-9536
Justina MedžiūnėThermo Fisher Scientific Baltics, Research and Development Department, Vilnius, Lithuania.
Varvara DubovskajaThermo Fisher Scientific Baltics, Research and Development Department, Vilnius, Lithuania.
Karolis MatjošaitisThermo Fisher Scientific Baltics, Research and Development Department, Vilnius, Lithuania.
Simona ŽeimytėThermo Fisher Scientific Baltics, Research and Development Department, Vilnius, Lithuania.
Arvydas LubysThermo Fisher Scientific Baltics, Research and Development Department, Vilnius, Lithuania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High-throughput RNA sequencing offers a comprehensive analysis of transcriptome complexity originated from regulatory events, such as differential gene expression, alternative polyadenylation and others, and allows the increase in diagnostic capacity and precision. For gene expression profiling applications that do not specifically require information on alternative splicing events, the mRNA 3' termini counting approach is a cost-effective alternative to whole transcriptome sequencing. Here, we report MTAS-seq (mRNA sequencing via terminator-assisted synthesis) - a novel RNA-seq library preparation method directed towards mRNA 3' termini. We demonstrate the specific enrichment for 3'-terminal regions by simple and quick single-tube protocol with built-in molecular barcoding to enable accurate estimation of transcript abundance. To achieve that, we synthesized oligonucleotide-modified dideoxynucleotides which enable the generation of cDNA libraries at the reverse transcription step. We validated the performance of MTAS-seq on well-characterized reference bulk RNA and further tested it with eukaryotic cell lysates.

Indexed as

OligonucleotidesTranscriptomeDNA, ComplementaryRNA, MessengerSequence Analysis, RNADNA, ComplementaryOligonucleotidesRNA, Messenger3’-end sequencinggene expression profilinglibrary preparationmodified nucleotidesRNA-seqtranscriptomics

Identifiers

PMID35653374
PMCPMC9191874

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.